|Other names||Retained products of conception|
|Specialty||Obstetrics and gynaecology|
- failed separation of the placenta from the uterine lining
- placenta separated from the uterine lining but retained within the uterus
Signs and symptoms
Risks of retained placenta include hemorrhage and infection. After the placenta is delivered, the uterus should contract down to close off all the blood vessels inside the uterus. If the placenta only partially separates, the uterus cannot contract properly, so the blood vessels inside will continue to bleed. A retained placenta thereby leads to hemorrhage.
Drugs, such as intraumbilical or intravenous oxytocin, are often used in the management of placental retention. It is useful ensuring the bladder is empty. However, ergometrine should not be given as it causes tonic uterine contractions which may delay placental expulsion. Controlled cord traction has been recommended as a second alternative after more than 30 minutes have passed after stimulation of uterine contractions, provided the uterus is contracted. Manual extraction may be required if cord traction also fails, or if heavy ongoing bleeding occurs. Very rarely a curettage is necessary to ensure that no remnants of the placenta remain (in rare conditions with very adherent placenta such as a placenta accreta).
However, in birth centers and attended home birth environments, it is common for licensed care providers to wait for the placenta's birth up to 2 hours in some instances.
- Placenta (retention)
- Maternity - Prevention, Early Recognition & Management of Postpartum Haemorrhage (PPH) From Department of Health, NSW. 21-Oct-2010
- Retained placenta, April 2015, BabyCenter, L.L.C.
- Duffy, James (2014). "What is the optimal pharmacological management of retained placenta?". BMJ. 349: g4778. doi:10.1136/bmj.g4778. PMID 25069774.
- Retained Placentas